BOCA RATON, Fla.--(BUSINESS WIRE)--Modernizing Medicine, Inc., the creator of the Electronic Medical Assistant® (EMA™), a cloud-based, specialty-specific electronic medical record (EMR) system, announced today that it has closed a $38 million Series E financing, bringing total capital raised to approximately $87 million.
The investors in the latest round of financing included Pentland Group and funds affiliated with Summit Partners and Sands Capital Ventures.
“We greatly appreciate the vote of confidence in the future growth of Modernizing Medicine,” shares Daniel Cane, co-founder and CEO of Modernizing Medicine. “While our dedication to the specialty-specific provider market is evidenced by sizable accomplishments – including four #1 EHR Black Book Rankings for dermatology, orthopedics, otolaryngology and gastroenterology – there still remains an opportunity to improve efficiencies and outcomes for physicians and patients alike.”
To learn more about Modernizing Medicine, visit www.modmed.com.
About Modernizing Medicine
Modernizing Medicine® is transforming how healthcare information is created, consumed and utilized in order to increase efficiency and improve outcomes. Our flagship product, Electronic Medical Assistant® (EMA™), is a cloud-based, specialty-specific electronic medical records (EMR) system built by practicing physicians. Available as a native iPad application and from almost any web-enabled Mac or PC, EMA adapts to each provider’s unique style of practice. This ICD-10 ready EMR system is available for the dermatology, ophthalmology, orthopedics, otolaryngology, gastroenterology, urology and plastic surgery markets and used by over 9,000 providers in the United States and its territories. The Modernizing Medicine family of companies also provides specialty-specific billing and inventory management, plus a gastroenterology platform consisting of an EMR system, Endoscopy Report Writer, practice management solution, patient portal, data analytics and revenue cycle management. Follow Modernizing Medicine on Twitter at www.modmed.com/twitter and on Facebook at www.modmed.com/facebook.
